Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 11;15(12):e50329.
doi: 10.7759/cureus.50329. eCollection 2023 Dec.

Knowledge About the Herpes Zoster (HZ) Vaccine and Its Acceptance Among the Population in Al-Ahsa City in the Kingdom of Saudi Arabia

Abdullah H Bohamad  1 , Heba Y Alojail  1 , Lujain A Alabdulmohsin  1 , Meshari A Alhawl  1 , Mishal B Aldossary  1 , Fatimah M Altoraiki  1 , Abdullatif Y Almulhim  1 , Abdullah Almulhim  1 , Shahd Alabdulathim  1 , Fatimah Almarri  1
Affiliations

Knowledge About the Herpes Zoster (HZ) Vaccine and Its Acceptance Among the Population in Al-Ahsa City in the Kingdom of Saudi Arabia

Abdullah H Bohamad et al. Cureus. .

Abstract

Introduction Herpes zoster (HZ), caused by the varicella-zoster virus (VZV), poses a public health concern in Saudi Arabia, with an increasing number of cases reported in recent years. This study aimed to assess the knowledge and acceptance of the herpes zoster vaccine among Saudi Arabian citizens in Al-Ahsa. Methodology A descriptive cross-sectional study was conducted using online surveys administered via social media platforms. The study was conducted in Al-Ahsa, a city located in the Eastern Province of Saudi Arabia. Al-Ahsa serves as a representative urban area within Saudi Arabia. Result The study found a high level of awareness and knowledge about the vaccine, with 78.2% of the participants having heard of herpes zoster. The majority considered the vaccine effective (89%) and believed it was available in Saudi Arabia (87%). However, the vaccination rate was only 8%. The study revealed varied opinions on the target population for vaccination, with 39.7% favoring immunocompromised patients and 38.1% choosing individuals above 50 years. The reasons for not being vaccinated included a lack of information (38.3%) and the belief of being in good health (37.3%). Conclusion The findings suggest a need for targeted educational campaigns to address misconceptions and promote vaccination, particularly among healthcare providers and the recommended target populations. Future research should explore barriers to vaccination to inform tailored interventions.

Keywords: acceptance; acceptance vzv; vaccination; vaccine; vzv; vzv vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

See all similar articles

Cited by

References

    1. Epidemiology, treatment and prevention of herpes zoster: a comprehensive review. Koshy E, Mengting L, Kumar H, Jianbo W. Indian J Dermatol Venereol Leprol. 2018;84:251–262. - PubMed
    1. Nair PA, Patel BC. Treasure Island, FL: StatPearls Publishing; 2023. Herpes zoster. - PubMed
    1. Prevention of herpes zoster: a focus on the effectiveness and safety of herpes zoster vaccines. Marra Y, Lalji F. Viruses. 2022;14:2667. - PMC - PubMed
    1. Clinical and epidemiological aspects of herpes zoster disease in a primary care setting in Riyadh, Saudi Arabia: a retrospective cohort study. Binsaeedu AS, Bajaber AO, Muqrad AG, Alendijani YA, Alkhenizan HA, Alsulaiman TA, Alkhenizan AH. J Family Med Prim Care. 2022;11:6433–6437. - PMC - PubMed
    1. Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age. Vermeulen JN, Lange JM, Tyring SK, et al. Vaccine. 2012;30:904–910. - PubMed

LinkOut - more resources